Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials
No Thumbnail Available
Identifiers
Date
2019-10-01
Authors
Ponce, S.
Calvo, E.
De Miguel, M. J.
Sessa, C.
Flor, M. J.
Drilon, A.
Falcon, A.
Sanchez Simon, I.
Nunez, R.
Luepke, X. E.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
SCLC, Lurbinectedin, Combination